“Selective GABAB receptor antagonist, CGP-55845, promotes remyelination and oligodendrocyte differentiation in rats with experimental autoimmune encephalomyelitis (EAE)”, J. Biol. Regul. Homeost. Agents, vol. 40, no. 1, p. 3807, Jan. 2026, doi: 10.54517/jbrha3807.